For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Defibrillation is a common treatment for life-threatening cardiac dysrhythmias, ventricular fibrillation and pulseless ventricular tachycardia. Defibrillation consists of delivering a therapeutic dose of electrical energy to the heart with a device called a defibrillator. This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia and allows normal sinus rhythm to be reestablished by the body's natural pacemaker, in the sinoatrial node of the heart. Defibrillators can be external, transvenous, or implanted (implantable cardioverter-defibrillator), depending on the type of device used or needed. Some external units, known as automated external defibrillators (AEDs), automate the diagnosis of treatable rhythms, meaning that lay responders or bystanders are able to use them successfully with little or no training at all.
Scope of the Report:
This report focuses on the Cardiac Defibrillators in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America accounted for a significant share of the overall market in 2016. This contribution can be attributed to increasing incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes, increasing awareness, and increase in training programs.
Asia Pacific was identified as the fastest growing market for defibrillators. Tremendous growth opportunities are observed in this region due to increasing awareness and accessibility of these devices. In addition, increasing prevalence of cardiovascular diseases in this region also supports growth of this segment.
The worldwide market for Cardiac Defibrillators is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- St. Jude Medical
- Boston Scientific
- Sorin Group
- Philips Healthcare
- Cardiac Science
- Zoll Medical
- HeartSine Technologies
- Welch Allyn(Zoll)
- GE Healthcare
- Nihon Kohden
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Automatic External Defibrillators
- Implantable Cardioverter Defibrillators
- Wearable Defibrillators
- Advanced Life Support (ALS) Defibrillators
Market Segment by Applications, can be divided into
- Specialty Clinics
- Ambulatory Surgical Centers
There are 15 Chapters to deeply display the global Cardiac Defibrillators market.
Chapter 1, to describe Cardiac Defibrillators Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiac Defibrillators, with sales, revenue, and price of Cardiac Defibrillators, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiac Defibrillators, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cardiac Defibrillators market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cardiac Defibrillators sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source